COVID-19 Impact on Global Haemophilia Treatment Market Insights, Forecast to 2026
Haemophilia Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Haemophilia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Haemophilia Treatment market is segmented into
The Haemophilia Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Haemophilia Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Haemophilia Treatment Market Share Analysis
Haemophilia Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Haemophilia Treatment business, the date to enter into the Haemophilia Treatment market, Haemophilia Treatment product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Haemophilia Treatment market is segmented into
- Haemophilia A
- Haemophilia B
- Hospital
- Pharmaceutical Companies
- Other
The Haemophilia Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Haemophilia Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Haemophilia Treatment Market Share Analysis
Haemophilia Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Haemophilia Treatment business, the date to enter into the Haemophilia Treatment market, Haemophilia Treatment product introduction, recent developments, etc.
The major vendors covered:
- Bayer
- Novo Nordisk
- Pfizer
- Roche
- Aptevo Therapeutics
- Catalyst BioSciences
- Dimension Therapeutics
- Takeda
- CSL Behring
- Alnylam Pharmaceuticals
1 STUDY COVERAGE
1.1 Haemophilia Treatment Product Introduction
1.2 Market Segments
1.3 Key Haemophilia Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Haemophilia Treatment Market Size Growth Rate by Type
1.4.2 Haemophilia A
1.4.3 Haemophilia B
1.5 Market by Application
1.5.1 Global Haemophilia Treatment Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Pharmaceutical Companies
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Haemophilia Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Haemophilia Treatment Industry
1.6.1.1 Haemophilia Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Haemophilia Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Haemophilia Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Haemophilia Treatment Market Size Estimates and Forecasts
2.1.1 Global Haemophilia Treatment Revenue 2015-2026
2.1.2 Global Haemophilia Treatment Sales 2015-2026
2.2 Haemophilia Treatment Market Size by Region: 2020 Versus 2026
2.2.1 Global Haemophilia Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Haemophilia Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL HAEMOPHILIA TREATMENT COMPETITOR LANDSCAPE BY PLAYERS
3.1 Haemophilia Treatment Sales by Manufacturers
3.1.1 Haemophilia Treatment Sales by Manufacturers (2015-2020)
3.1.2 Haemophilia Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Haemophilia Treatment Revenue by Manufacturers
3.2.1 Haemophilia Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Haemophilia Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Haemophilia Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Haemophilia Treatment Revenue in 2019
3.2.5 Global Haemophilia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Haemophilia Treatment Price by Manufacturers
3.4 Haemophilia Treatment Manufacturing Base Distribution, Product Types
3.4.1 Haemophilia Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Haemophilia Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Haemophilia Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Haemophilia Treatment Market Size by Type (2015-2020)
4.1.1 Global Haemophilia Treatment Sales by Type (2015-2020)
4.1.2 Global Haemophilia Treatment Revenue by Type (2015-2020)
4.1.3 Haemophilia Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Haemophilia Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Haemophilia Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Haemophilia Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Haemophilia Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Haemophilia Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Haemophilia Treatment Market Size by Application (2015-2020)
5.1.1 Global Haemophilia Treatment Sales by Application (2015-2020)
5.1.2 Global Haemophilia Treatment Revenue by Application (2015-2020)
5.1.3 Haemophilia Treatment Price by Application (2015-2020)
5.2 Haemophilia Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Haemophilia Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Haemophilia Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Haemophilia Treatment Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Haemophilia Treatment by Country
6.1.1 North America Haemophilia Treatment Sales by Country
6.1.2 North America Haemophilia Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Haemophilia Treatment Market Facts & Figures by Type
6.3 North America Haemophilia Treatment Market Facts & Figures by Application
7 EUROPE
7.1 Europe Haemophilia Treatment by Country
7.1.1 Europe Haemophilia Treatment Sales by Country
7.1.2 Europe Haemophilia Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Haemophilia Treatment Market Facts & Figures by Type
7.3 Europe Haemophilia Treatment Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Haemophilia Treatment by Region
8.1.1 Asia Pacific Haemophilia Treatment Sales by Region
8.1.2 Asia Pacific Haemophilia Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Haemophilia Treatment Market Facts & Figures by Type
8.3 Asia Pacific Haemophilia Treatment Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Haemophilia Treatment by Country
9.1.1 Latin America Haemophilia Treatment Sales by Country
9.1.2 Latin America Haemophilia Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Haemophilia Treatment Market Facts & Figures by Type
9.3 Central & South America Haemophilia Treatment Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Haemophilia Treatment by Country
10.1.1 Middle East and Africa Haemophilia Treatment Sales by Country
10.1.2 Middle East and Africa Haemophilia Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Haemophilia Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Haemophilia Treatment Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description, Business Overview and Total Revenue
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Haemophilia Treatment Products Offered
11.1.5 Bayer Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Corporation Information
11.2.2 Novo Nordisk Description, Business Overview and Total Revenue
11.2.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novo Nordisk Haemophilia Treatment Products Offered
11.2.5 Novo Nordisk Recent Development
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description, Business Overview and Total Revenue
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Haemophilia Treatment Products Offered
11.3.5 Pfizer Recent Development
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Description, Business Overview and Total Revenue
11.4.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Roche Haemophilia Treatment Products Offered
11.4.5 Roche Recent Development
11.5 Aptevo Therapeutics
11.5.1 Aptevo Therapeutics Corporation Information
11.5.2 Aptevo Therapeutics Description, Business Overview and Total Revenue
11.5.3 Aptevo Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Aptevo Therapeutics Haemophilia Treatment Products Offered
11.5.5 Aptevo Therapeutics Recent Development
11.6 Catalyst BioSciences
11.6.1 Catalyst BioSciences Corporation Information
11.6.2 Catalyst BioSciences Description, Business Overview and Total Revenue
11.6.3 Catalyst BioSciences Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Catalyst BioSciences Haemophilia Treatment Products Offered
11.6.5 Catalyst BioSciences Recent Development
11.7 Dimension Therapeutics
11.7.1 Dimension Therapeutics Corporation Information
11.7.2 Dimension Therapeutics Description, Business Overview and Total Revenue
11.7.3 Dimension Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Dimension Therapeutics Haemophilia Treatment Products Offered
11.7.5 Dimension Therapeutics Recent Development
11.8 Takeda
11.8.1 Takeda Corporation Information
11.8.2 Takeda Description, Business Overview and Total Revenue
11.8.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Takeda Haemophilia Treatment Products Offered
11.8.5 Takeda Recent Development
11.9 CSL Behring
11.9.1 CSL Behring Corporation Information
11.9.2 CSL Behring Description, Business Overview and Total Revenue
11.9.3 CSL Behring Sales, Revenue and Gross Margin (2015-2020)
11.9.4 CSL Behring Haemophilia Treatment Products Offered
11.9.5 CSL Behring Recent Development
11.10 Alnylam Pharmaceuticals
11.10.1 Alnylam Pharmaceuticals Corporation Information
11.10.2 Alnylam Pharmaceuticals Description, Business Overview and Total Revenue
11.10.3 Alnylam Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Alnylam Pharmaceuticals Haemophilia Treatment Products Offered
11.10.5 Alnylam Pharmaceuticals Recent Development
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description, Business Overview and Total Revenue
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Haemophilia Treatment Products Offered
11.1.5 Bayer Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Haemophilia Treatment Market Estimates and Projections by Region
12.1.1 Global Haemophilia Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Haemophilia Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Haemophilia Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Haemophilia Treatment Sales Forecast (2021-2026)
12.2.2 North America: Haemophilia Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Haemophilia Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Haemophilia Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Haemophilia Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Haemophilia Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Haemophilia Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Haemophilia Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Haemophilia Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Haemophilia Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Haemophilia Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Haemophilia Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Haemophilia Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Haemophilia Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Haemophilia Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Haemophilia Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Haemophilia Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Haemophilia Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Haemophilia Treatment Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Haemophilia Treatment Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Haemophilia Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Haemophilia Treatment Product Introduction
1.2 Market Segments
1.3 Key Haemophilia Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Haemophilia Treatment Market Size Growth Rate by Type
1.4.2 Haemophilia A
1.4.3 Haemophilia B
1.5 Market by Application
1.5.1 Global Haemophilia Treatment Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Pharmaceutical Companies
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Haemophilia Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Haemophilia Treatment Industry
1.6.1.1 Haemophilia Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Haemophilia Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Haemophilia Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Haemophilia Treatment Market Size Estimates and Forecasts
2.1.1 Global Haemophilia Treatment Revenue 2015-2026
2.1.2 Global Haemophilia Treatment Sales 2015-2026
2.2 Haemophilia Treatment Market Size by Region: 2020 Versus 2026
2.2.1 Global Haemophilia Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Haemophilia Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL HAEMOPHILIA TREATMENT COMPETITOR LANDSCAPE BY PLAYERS
3.1 Haemophilia Treatment Sales by Manufacturers
3.1.1 Haemophilia Treatment Sales by Manufacturers (2015-2020)
3.1.2 Haemophilia Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Haemophilia Treatment Revenue by Manufacturers
3.2.1 Haemophilia Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Haemophilia Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Haemophilia Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Haemophilia Treatment Revenue in 2019
3.2.5 Global Haemophilia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Haemophilia Treatment Price by Manufacturers
3.4 Haemophilia Treatment Manufacturing Base Distribution, Product Types
3.4.1 Haemophilia Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Haemophilia Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Haemophilia Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Haemophilia Treatment Market Size by Type (2015-2020)
4.1.1 Global Haemophilia Treatment Sales by Type (2015-2020)
4.1.2 Global Haemophilia Treatment Revenue by Type (2015-2020)
4.1.3 Haemophilia Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Haemophilia Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Haemophilia Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Haemophilia Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Haemophilia Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Haemophilia Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Haemophilia Treatment Market Size by Application (2015-2020)
5.1.1 Global Haemophilia Treatment Sales by Application (2015-2020)
5.1.2 Global Haemophilia Treatment Revenue by Application (2015-2020)
5.1.3 Haemophilia Treatment Price by Application (2015-2020)
5.2 Haemophilia Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Haemophilia Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Haemophilia Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Haemophilia Treatment Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Haemophilia Treatment by Country
6.1.1 North America Haemophilia Treatment Sales by Country
6.1.2 North America Haemophilia Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Haemophilia Treatment Market Facts & Figures by Type
6.3 North America Haemophilia Treatment Market Facts & Figures by Application
7 EUROPE
7.1 Europe Haemophilia Treatment by Country
7.1.1 Europe Haemophilia Treatment Sales by Country
7.1.2 Europe Haemophilia Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Haemophilia Treatment Market Facts & Figures by Type
7.3 Europe Haemophilia Treatment Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Haemophilia Treatment by Region
8.1.1 Asia Pacific Haemophilia Treatment Sales by Region
8.1.2 Asia Pacific Haemophilia Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Haemophilia Treatment Market Facts & Figures by Type
8.3 Asia Pacific Haemophilia Treatment Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Haemophilia Treatment by Country
9.1.1 Latin America Haemophilia Treatment Sales by Country
9.1.2 Latin America Haemophilia Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Haemophilia Treatment Market Facts & Figures by Type
9.3 Central & South America Haemophilia Treatment Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Haemophilia Treatment by Country
10.1.1 Middle East and Africa Haemophilia Treatment Sales by Country
10.1.2 Middle East and Africa Haemophilia Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Haemophilia Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Haemophilia Treatment Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description, Business Overview and Total Revenue
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Haemophilia Treatment Products Offered
11.1.5 Bayer Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Corporation Information
11.2.2 Novo Nordisk Description, Business Overview and Total Revenue
11.2.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novo Nordisk Haemophilia Treatment Products Offered
11.2.5 Novo Nordisk Recent Development
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description, Business Overview and Total Revenue
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Haemophilia Treatment Products Offered
11.3.5 Pfizer Recent Development
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Description, Business Overview and Total Revenue
11.4.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Roche Haemophilia Treatment Products Offered
11.4.5 Roche Recent Development
11.5 Aptevo Therapeutics
11.5.1 Aptevo Therapeutics Corporation Information
11.5.2 Aptevo Therapeutics Description, Business Overview and Total Revenue
11.5.3 Aptevo Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Aptevo Therapeutics Haemophilia Treatment Products Offered
11.5.5 Aptevo Therapeutics Recent Development
11.6 Catalyst BioSciences
11.6.1 Catalyst BioSciences Corporation Information
11.6.2 Catalyst BioSciences Description, Business Overview and Total Revenue
11.6.3 Catalyst BioSciences Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Catalyst BioSciences Haemophilia Treatment Products Offered
11.6.5 Catalyst BioSciences Recent Development
11.7 Dimension Therapeutics
11.7.1 Dimension Therapeutics Corporation Information
11.7.2 Dimension Therapeutics Description, Business Overview and Total Revenue
11.7.3 Dimension Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Dimension Therapeutics Haemophilia Treatment Products Offered
11.7.5 Dimension Therapeutics Recent Development
11.8 Takeda
11.8.1 Takeda Corporation Information
11.8.2 Takeda Description, Business Overview and Total Revenue
11.8.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Takeda Haemophilia Treatment Products Offered
11.8.5 Takeda Recent Development
11.9 CSL Behring
11.9.1 CSL Behring Corporation Information
11.9.2 CSL Behring Description, Business Overview and Total Revenue
11.9.3 CSL Behring Sales, Revenue and Gross Margin (2015-2020)
11.9.4 CSL Behring Haemophilia Treatment Products Offered
11.9.5 CSL Behring Recent Development
11.10 Alnylam Pharmaceuticals
11.10.1 Alnylam Pharmaceuticals Corporation Information
11.10.2 Alnylam Pharmaceuticals Description, Business Overview and Total Revenue
11.10.3 Alnylam Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Alnylam Pharmaceuticals Haemophilia Treatment Products Offered
11.10.5 Alnylam Pharmaceuticals Recent Development
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description, Business Overview and Total Revenue
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Haemophilia Treatment Products Offered
11.1.5 Bayer Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Haemophilia Treatment Market Estimates and Projections by Region
12.1.1 Global Haemophilia Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Haemophilia Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Haemophilia Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Haemophilia Treatment Sales Forecast (2021-2026)
12.2.2 North America: Haemophilia Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Haemophilia Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Haemophilia Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Haemophilia Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Haemophilia Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Haemophilia Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Haemophilia Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Haemophilia Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Haemophilia Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Haemophilia Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Haemophilia Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Haemophilia Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Haemophilia Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Haemophilia Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Haemophilia Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Haemophilia Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Haemophilia Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Haemophilia Treatment Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Haemophilia Treatment Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Haemophilia Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Haemophilia Treatment Market Segments
Table 2. Ranking of Global Top Haemophilia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Haemophilia Treatment Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Haemophilia A
Table 5. Major Manufacturers of Haemophilia B
Table 6. COVID-19 Impact Global Market: (Four Haemophilia Treatment Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Haemophilia Treatment Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Haemophilia Treatment Players to Combat Covid-19 Impact
Table 11. Global Haemophilia Treatment Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Haemophilia Treatment Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Haemophilia Treatment Sales by Regions 2015-2020 (K Units)
Table 14. Global Haemophilia Treatment Sales Market Share by Regions (2015-2020)
Table 15. Global Haemophilia Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Haemophilia Treatment Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Haemophilia Treatment Sales Share by Manufacturers (2015-2020)
Table 18. Global Haemophilia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Haemophilia Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Haemophilia Treatment as of 2019)
Table 20. Haemophilia Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Haemophilia Treatment Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Haemophilia Treatment Price (2015-2020) (USD/Unit)
Table 23. Haemophilia Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Haemophilia Treatment Product Type
Table 25. Date of International Manufacturers Enter into Haemophilia Treatment Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Haemophilia Treatment Sales by Type (2015-2020) (K Units)
Table 28. Global Haemophilia Treatment Sales Share by Type (2015-2020)
Table 29. Global Haemophilia Treatment Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Haemophilia Treatment Revenue Share by Type (2015-2020)
Table 31. Haemophilia Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Haemophilia Treatment Sales by Application (2015-2020) (K Units)
Table 33. Global Haemophilia Treatment Sales Share by Application (2015-2020)
Table 34. North America Haemophilia Treatment Sales by Country (2015-2020) (K Units)
Table 35. North America Haemophilia Treatment Sales Market Share by Country (2015-2020)
Table 36. North America Haemophilia Treatment Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Haemophilia Treatment Revenue Market Share by Country (2015-2020)
Table 38. North America Haemophilia Treatment Sales by Type (2015-2020) (K Units)
Table 39. North America Haemophilia Treatment Sales Market Share by Type (2015-2020)
Table 40. North America Haemophilia Treatment Sales by Application (2015-2020) (K Units)
Table 41. North America Haemophilia Treatment Sales Market Share by Application (2015-2020)
Table 42. Europe Haemophilia Treatment Sales by Country (2015-2020) (K Units)
Table 43. Europe Haemophilia Treatment Sales Market Share by Country (2015-2020)
Table 44. Europe Haemophilia Treatment Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Haemophilia Treatment Revenue Market Share by Country (2015-2020)
Table 46. Europe Haemophilia Treatment Sales by Type (2015-2020) (K Units)
Table 47. Europe Haemophilia Treatment Sales Market Share by Type (2015-2020)
Table 48. Europe Haemophilia Treatment Sales by Application (2015-2020) (K Units)
Table 49. Europe Haemophilia Treatment Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Haemophilia Treatment Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Haemophilia Treatment Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Haemophilia Treatment Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Haemophilia Treatment Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Haemophilia Treatment Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Haemophilia Treatment Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Haemophilia Treatment Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Haemophilia Treatment Sales Market Share by Application (2015-2020)
Table 58. Latin America Haemophilia Treatment Sales by Country (2015-2020) (K Units)
Table 59. Latin America Haemophilia Treatment Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Haemophilia Treatment Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Haemophilia Treatment Revenue Market Share by Country (2015-2020)
Table 62. Latin America Haemophilia Treatment Sales by Type (2015-2020) (K Units)
Table 63. Latin America Haemophilia Treatment Sales Market Share by Type (2015-2020)
Table 64. Latin America Haemophilia Treatment Sales by Application (2015-2020) (K Units)
Table 65. Latin America Haemophilia Treatment Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Haemophilia Treatment Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Haemophilia Treatment Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Haemophilia Treatment Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Haemophilia Treatment Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Haemophilia Treatment Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Haemophilia Treatment Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Haemophilia Treatment Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Haemophilia Treatment Sales Market Share by Application (2015-2020)
Table 74. Bayer Corporation Information
Table 75. Bayer Description and Major Businesses
Table 76. Bayer Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Bayer Product
Table 78. Bayer Recent Development
Table 79. Novo Nordisk Corporation Information
Table 80. Novo Nordisk Description and Major Businesses
Table 81. Novo Nordisk Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Novo Nordisk Product
Table 83. Novo Nordisk Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Major Businesses
Table 86. Pfizer Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. Roche Corporation Information
Table 90. Roche Description and Major Businesses
Table 91. Roche Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Roche Product
Table 93. Roche Recent Development
Table 94. Aptevo Therapeutics Corporation Information
Table 95. Aptevo Therapeutics Description and Major Businesses
Table 96. Aptevo Therapeutics Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Aptevo Therapeutics Product
Table 98. Aptevo Therapeutics Recent Development
Table 99. Catalyst BioSciences Corporation Information
Table 100. Catalyst BioSciences Description and Major Businesses
Table 101. Catalyst BioSciences Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Catalyst BioSciences Product
Table 103. Catalyst BioSciences Recent Development
Table 104. Dimension Therapeutics Corporation Information
Table 105. Dimension Therapeutics Description and Major Businesses
Table 106. Dimension Therapeutics Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Dimension Therapeutics Product
Table 108. Dimension Therapeutics Recent Development
Table 109. Takeda Corporation Information
Table 110. Takeda Description and Major Businesses
Table 111. Takeda Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Takeda Product
Table 113. Takeda Recent Development
Table 114. CSL Behring Corporation Information
Table 115. CSL Behring Description and Major Businesses
Table 116. CSL Behring Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. CSL Behring Product
Table 118. CSL Behring Recent Development
Table 119. Alnylam Pharmaceuticals Corporation Information
Table 120. Alnylam Pharmaceuticals Description and Major Businesses
Table 121. Alnylam Pharmaceuticals Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Alnylam Pharmaceuticals Product
Table 123. Alnylam Pharmaceuticals Recent Development
Table 124. Global Haemophilia Treatment Sales Forecast by Regions (2021-2026) (K Units)
Table 125. Global Haemophilia Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Haemophilia Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Haemophilia Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Haemophilia Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 129. North America: Haemophilia Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Haemophilia Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 131. Europe: Haemophilia Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Haemophilia Treatment Sales Forecast by Region (2021-2026) (K Units)
Table 133. Asia Pacific: Haemophilia Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Haemophilia Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 135. Latin America: Haemophilia Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Haemophilia Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 137. Middle East and Africa: Haemophilia Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Haemophilia Treatment Players
Table 142. Haemophilia Treatment Customers List
Table 143. Haemophilia Treatment Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 1. Haemophilia Treatment Market Segments
Table 2. Ranking of Global Top Haemophilia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Haemophilia Treatment Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Haemophilia A
Table 5. Major Manufacturers of Haemophilia B
Table 6. COVID-19 Impact Global Market: (Four Haemophilia Treatment Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Haemophilia Treatment Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Haemophilia Treatment Players to Combat Covid-19 Impact
Table 11. Global Haemophilia Treatment Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Haemophilia Treatment Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Haemophilia Treatment Sales by Regions 2015-2020 (K Units)
Table 14. Global Haemophilia Treatment Sales Market Share by Regions (2015-2020)
Table 15. Global Haemophilia Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Haemophilia Treatment Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Haemophilia Treatment Sales Share by Manufacturers (2015-2020)
Table 18. Global Haemophilia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Haemophilia Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Haemophilia Treatment as of 2019)
Table 20. Haemophilia Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Haemophilia Treatment Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Haemophilia Treatment Price (2015-2020) (USD/Unit)
Table 23. Haemophilia Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Haemophilia Treatment Product Type
Table 25. Date of International Manufacturers Enter into Haemophilia Treatment Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Haemophilia Treatment Sales by Type (2015-2020) (K Units)
Table 28. Global Haemophilia Treatment Sales Share by Type (2015-2020)
Table 29. Global Haemophilia Treatment Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Haemophilia Treatment Revenue Share by Type (2015-2020)
Table 31. Haemophilia Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Haemophilia Treatment Sales by Application (2015-2020) (K Units)
Table 33. Global Haemophilia Treatment Sales Share by Application (2015-2020)
Table 34. North America Haemophilia Treatment Sales by Country (2015-2020) (K Units)
Table 35. North America Haemophilia Treatment Sales Market Share by Country (2015-2020)
Table 36. North America Haemophilia Treatment Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Haemophilia Treatment Revenue Market Share by Country (2015-2020)
Table 38. North America Haemophilia Treatment Sales by Type (2015-2020) (K Units)
Table 39. North America Haemophilia Treatment Sales Market Share by Type (2015-2020)
Table 40. North America Haemophilia Treatment Sales by Application (2015-2020) (K Units)
Table 41. North America Haemophilia Treatment Sales Market Share by Application (2015-2020)
Table 42. Europe Haemophilia Treatment Sales by Country (2015-2020) (K Units)
Table 43. Europe Haemophilia Treatment Sales Market Share by Country (2015-2020)
Table 44. Europe Haemophilia Treatment Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Haemophilia Treatment Revenue Market Share by Country (2015-2020)
Table 46. Europe Haemophilia Treatment Sales by Type (2015-2020) (K Units)
Table 47. Europe Haemophilia Treatment Sales Market Share by Type (2015-2020)
Table 48. Europe Haemophilia Treatment Sales by Application (2015-2020) (K Units)
Table 49. Europe Haemophilia Treatment Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Haemophilia Treatment Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Haemophilia Treatment Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Haemophilia Treatment Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Haemophilia Treatment Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Haemophilia Treatment Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Haemophilia Treatment Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Haemophilia Treatment Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Haemophilia Treatment Sales Market Share by Application (2015-2020)
Table 58. Latin America Haemophilia Treatment Sales by Country (2015-2020) (K Units)
Table 59. Latin America Haemophilia Treatment Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Haemophilia Treatment Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Haemophilia Treatment Revenue Market Share by Country (2015-2020)
Table 62. Latin America Haemophilia Treatment Sales by Type (2015-2020) (K Units)
Table 63. Latin America Haemophilia Treatment Sales Market Share by Type (2015-2020)
Table 64. Latin America Haemophilia Treatment Sales by Application (2015-2020) (K Units)
Table 65. Latin America Haemophilia Treatment Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Haemophilia Treatment Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Haemophilia Treatment Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Haemophilia Treatment Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Haemophilia Treatment Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Haemophilia Treatment Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Haemophilia Treatment Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Haemophilia Treatment Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Haemophilia Treatment Sales Market Share by Application (2015-2020)
Table 74. Bayer Corporation Information
Table 75. Bayer Description and Major Businesses
Table 76. Bayer Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Bayer Product
Table 78. Bayer Recent Development
Table 79. Novo Nordisk Corporation Information
Table 80. Novo Nordisk Description and Major Businesses
Table 81. Novo Nordisk Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Novo Nordisk Product
Table 83. Novo Nordisk Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Major Businesses
Table 86. Pfizer Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. Roche Corporation Information
Table 90. Roche Description and Major Businesses
Table 91. Roche Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Roche Product
Table 93. Roche Recent Development
Table 94. Aptevo Therapeutics Corporation Information
Table 95. Aptevo Therapeutics Description and Major Businesses
Table 96. Aptevo Therapeutics Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Aptevo Therapeutics Product
Table 98. Aptevo Therapeutics Recent Development
Table 99. Catalyst BioSciences Corporation Information
Table 100. Catalyst BioSciences Description and Major Businesses
Table 101. Catalyst BioSciences Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Catalyst BioSciences Product
Table 103. Catalyst BioSciences Recent Development
Table 104. Dimension Therapeutics Corporation Information
Table 105. Dimension Therapeutics Description and Major Businesses
Table 106. Dimension Therapeutics Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Dimension Therapeutics Product
Table 108. Dimension Therapeutics Recent Development
Table 109. Takeda Corporation Information
Table 110. Takeda Description and Major Businesses
Table 111. Takeda Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Takeda Product
Table 113. Takeda Recent Development
Table 114. CSL Behring Corporation Information
Table 115. CSL Behring Description and Major Businesses
Table 116. CSL Behring Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. CSL Behring Product
Table 118. CSL Behring Recent Development
Table 119. Alnylam Pharmaceuticals Corporation Information
Table 120. Alnylam Pharmaceuticals Description and Major Businesses
Table 121. Alnylam Pharmaceuticals Haemophilia Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Alnylam Pharmaceuticals Product
Table 123. Alnylam Pharmaceuticals Recent Development
Table 124. Global Haemophilia Treatment Sales Forecast by Regions (2021-2026) (K Units)
Table 125. Global Haemophilia Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Haemophilia Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Haemophilia Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Haemophilia Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 129. North America: Haemophilia Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Haemophilia Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 131. Europe: Haemophilia Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Haemophilia Treatment Sales Forecast by Region (2021-2026) (K Units)
Table 133. Asia Pacific: Haemophilia Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Haemophilia Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 135. Latin America: Haemophilia Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Haemophilia Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 137. Middle East and Africa: Haemophilia Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Haemophilia Treatment Players
Table 142. Haemophilia Treatment Customers List
Table 143. Haemophilia Treatment Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Haemophilia Treatment Product Picture
Figure 2. Global Haemophilia Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Haemophilia A Product Picture
Figure 4. Haemophilia B Product Picture
Figure 5. Global Haemophilia Treatment Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Pharmaceutical Companies
Figure 8. Other
Figure 9. Haemophilia Treatment Report Years Considered
Figure 10. Global Haemophilia Treatment Market Size 2015-2026 (US$ Million)
Figure 11. Global Haemophilia Treatment Sales 2015-2026 (K Units)
Figure 12. Global Haemophilia Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Haemophilia Treatment Sales Market Share by Region (2015-2020)
Figure 14. Global Haemophilia Treatment Sales Market Share by Region in 2019
Figure 15. Global Haemophilia Treatment Revenue Market Share by Region (2015-2020)
Figure 16. Global Haemophilia Treatment Revenue Market Share by Region in 2019
Figure 17. Global Haemophilia Treatment Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Haemophilia Treatment Revenue in 2019
Figure 19. Haemophilia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Haemophilia Treatment Sales Market Share by Type (2015-2020)
Figure 21. Global Haemophilia Treatment Sales Market Share by Type in 2019
Figure 22. Global Haemophilia Treatment Revenue Market Share by Type (2015-2020)
Figure 23. Global Haemophilia Treatment Revenue Market Share by Type in 2019
Figure 24. Global Haemophilia Treatment Market Share by Price Range (2015-2020)
Figure 25. Global Haemophilia Treatment Sales Market Share by Application (2015-2020)
Figure 26. Global Haemophilia Treatment Sales Market Share by Application in 2019
Figure 27. Global Haemophilia Treatment Revenue Market Share by Application (2015-2020)
Figure 28. Global Haemophilia Treatment Revenue Market Share by Application in 2019
Figure 29. North America Haemophilia Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Haemophilia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Haemophilia Treatment Sales Market Share by Country in 2019
Figure 32. North America Haemophilia Treatment Revenue Market Share by Country in 2019
Figure 33. U.S. Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Haemophilia Treatment Market Share by Type in 2019
Figure 38. North America Haemophilia Treatment Market Share by Application in 2019
Figure 39. Europe Haemophilia Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Haemophilia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Haemophilia Treatment Sales Market Share by Country in 2019
Figure 42. Europe Haemophilia Treatment Revenue Market Share by Country in 2019
Figure 43. Germany Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Haemophilia Treatment Market Share by Type in 2019
Figure 54. Europe Haemophilia Treatment Market Share by Application in 2019
Figure 55. Asia Pacific Haemophilia Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Haemophilia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Haemophilia Treatment Sales Market Share by Region in 2019
Figure 58. Asia Pacific Haemophilia Treatment Revenue Market Share by Region in 2019
Figure 59. China Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Haemophilia Treatment Market Share by Type in 2019
Figure 82. Asia Pacific Haemophilia Treatment Market Share by Application in 2019
Figure 83. Latin America Haemophilia Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Haemophilia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Haemophilia Treatment Sales Market Share by Country in 2019
Figure 86. Latin America Haemophilia Treatment Revenue Market Share by Country in 2019
Figure 87. Mexico Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Haemophilia Treatment Market Share by Type in 2019
Figure 94. Latin America Haemophilia Treatment Market Share by Application in 2019
Figure 95. Middle East and Africa Haemophilia Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Haemophilia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Haemophilia Treatment Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Haemophilia Treatment Revenue Market Share by Country in 2019
Figure 99. Turkey Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Haemophilia Treatment Market Share by Type in 2019
Figure 106. Middle East and Africa Haemophilia Treatment Market Share by Application in 2019
Figure 107. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Aptevo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Catalyst BioSciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Dimension Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Alnylam Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America Haemophilia Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. North America Haemophilia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Haemophilia Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Europe Haemophilia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific Haemophilia Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Asia Pacific Haemophilia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America Haemophilia Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Latin America Haemophilia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa Haemophilia Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Middle East and Africa Haemophilia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed
Figure 1. Haemophilia Treatment Product Picture
Figure 2. Global Haemophilia Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Haemophilia A Product Picture
Figure 4. Haemophilia B Product Picture
Figure 5. Global Haemophilia Treatment Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Pharmaceutical Companies
Figure 8. Other
Figure 9. Haemophilia Treatment Report Years Considered
Figure 10. Global Haemophilia Treatment Market Size 2015-2026 (US$ Million)
Figure 11. Global Haemophilia Treatment Sales 2015-2026 (K Units)
Figure 12. Global Haemophilia Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Haemophilia Treatment Sales Market Share by Region (2015-2020)
Figure 14. Global Haemophilia Treatment Sales Market Share by Region in 2019
Figure 15. Global Haemophilia Treatment Revenue Market Share by Region (2015-2020)
Figure 16. Global Haemophilia Treatment Revenue Market Share by Region in 2019
Figure 17. Global Haemophilia Treatment Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Haemophilia Treatment Revenue in 2019
Figure 19. Haemophilia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Haemophilia Treatment Sales Market Share by Type (2015-2020)
Figure 21. Global Haemophilia Treatment Sales Market Share by Type in 2019
Figure 22. Global Haemophilia Treatment Revenue Market Share by Type (2015-2020)
Figure 23. Global Haemophilia Treatment Revenue Market Share by Type in 2019
Figure 24. Global Haemophilia Treatment Market Share by Price Range (2015-2020)
Figure 25. Global Haemophilia Treatment Sales Market Share by Application (2015-2020)
Figure 26. Global Haemophilia Treatment Sales Market Share by Application in 2019
Figure 27. Global Haemophilia Treatment Revenue Market Share by Application (2015-2020)
Figure 28. Global Haemophilia Treatment Revenue Market Share by Application in 2019
Figure 29. North America Haemophilia Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Haemophilia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Haemophilia Treatment Sales Market Share by Country in 2019
Figure 32. North America Haemophilia Treatment Revenue Market Share by Country in 2019
Figure 33. U.S. Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Haemophilia Treatment Market Share by Type in 2019
Figure 38. North America Haemophilia Treatment Market Share by Application in 2019
Figure 39. Europe Haemophilia Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Haemophilia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Haemophilia Treatment Sales Market Share by Country in 2019
Figure 42. Europe Haemophilia Treatment Revenue Market Share by Country in 2019
Figure 43. Germany Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Haemophilia Treatment Market Share by Type in 2019
Figure 54. Europe Haemophilia Treatment Market Share by Application in 2019
Figure 55. Asia Pacific Haemophilia Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Haemophilia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Haemophilia Treatment Sales Market Share by Region in 2019
Figure 58. Asia Pacific Haemophilia Treatment Revenue Market Share by Region in 2019
Figure 59. China Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Haemophilia Treatment Market Share by Type in 2019
Figure 82. Asia Pacific Haemophilia Treatment Market Share by Application in 2019
Figure 83. Latin America Haemophilia Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Haemophilia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Haemophilia Treatment Sales Market Share by Country in 2019
Figure 86. Latin America Haemophilia Treatment Revenue Market Share by Country in 2019
Figure 87. Mexico Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Haemophilia Treatment Market Share by Type in 2019
Figure 94. Latin America Haemophilia Treatment Market Share by Application in 2019
Figure 95. Middle East and Africa Haemophilia Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Haemophilia Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Haemophilia Treatment Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Haemophilia Treatment Revenue Market Share by Country in 2019
Figure 99. Turkey Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Haemophilia Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Haemophilia Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Haemophilia Treatment Market Share by Type in 2019
Figure 106. Middle East and Africa Haemophilia Treatment Market Share by Application in 2019
Figure 107. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Aptevo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Catalyst BioSciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Dimension Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Alnylam Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America Haemophilia Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. North America Haemophilia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Haemophilia Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Europe Haemophilia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific Haemophilia Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Asia Pacific Haemophilia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America Haemophilia Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Latin America Haemophilia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa Haemophilia Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Middle East and Africa Haemophilia Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed
